InvestorsHub Logo
icon url

golf stud

06/09/23 1:22 PM

#410436 RE: Pharmacydude #410435

Dude does that mean that if brave is successful that it would be huge in Europe because we have exclusivity?
icon url

Whalatane

06/09/23 1:52 PM

#410441 RE: Pharmacydude #410435

PD. I doubt Germany ( and probably also France ) will cover Vazkepa at a price acceptable to AMRN without independent confirmation of at least the R-IT PCI risk reduction numbers ....
How AMRN generates that independent confirmation ...MITGATE or RWE ( real world evidence ) remains to be seen .
Meanwhile we have HEART UK starting July 5th with AMRN running a symposia on Icosapent-ethyly ( Vazkepa )
So we should see in the 3 months following that ...how effective AMRN has been in generating sales in the UK . Thx to Capt for tracking that data .
Re Denner vs KM . KM is a salesman and would have milked AMRN for as long as he could. Denner is motivated to at least get his money back and will try and maneuver the Co into a position where he can sell it.
JMO
Kiwi